Nolato AB (NOLA.B) AI Stock Analysis

• Market Cap: $16.27B
• Dividend Yield: 2.45%
• Average Volume (3M): 189.00K
• Price to Earnings (P/E): 20.6
• Beta (1Y): 0.98
• Revenue Growth: 0.40%
• EPS Growth: 38.42%
• Country: SE
• Employees: 5,405
• Sector: Healthcare
• Sector Strength: 45
• Industry: Conglomerates
• EPS (TTM): 0.80
• Shares Outstanding: 241,783,080
• 10 Day Avg. Volume: 114,289
• 30 Day Avg. Volume: 189,000
• PEG Ratio: 0.43
• Price to Book (P/B): 2.54
• Price to Sales (P/S): 1.51
• P/FCF Ratio: 19.68
• Enterprise Value/Market Cap: 1.04
• Enterprise Value/Revenue: 1.77
• Enterprise Value/Gross Profit: 9.94
• Enterprise Value/Ebitda: 10.56
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 73 Outperform
• Price Target: kr69.00 ▲(12.75% Upside)

Nolato AB's overall stock score reflects strong financial performance and positive technical indicators, supported by a positive earnings call. However, challenges in revenue growth and cash flow, along with a moderate valuation, temper the overall outlook.

Positive Factors

Strong Profitability

Nolato's strong profitability and low leverage indicate efficient operations and financial stability, supporting long-term growth potential.

Margin Improvements

Improved margins across business areas reflect operational efficiency and cost management, enhancing long-term profitability.

Expansion Projects

Expansion projects in key regions support future revenue growth and market presence, strengthening Nolato's competitive position.

Negative Factors

Decline in Revenue Growth

A significant decline in revenue growth indicates challenges in market demand or competition, potentially impacting future earnings.

Lower Cash Flow

Reduced cash flow limits the company's ability to reinvest in growth opportunities or return capital to shareholders, affecting liquidity.

Underutilization in China

Underutilization in China suggests inefficiencies and potential lost revenue, which may hinder growth in a key market.

Nolato AB Business Overview & Revenue Model

Company Description

Nolato AB is a Swedish multinational company specializing in polymer technology and advanced manufacturing solutions. It operates primarily in two sectors: Medical and Industrial. Nolato provides a diverse range of products and services, including medical devices, pharmaceutical packaging, and advanced industrial solutions, leveraging its expertise in injection molding and advanced polymer materials.

How the Company Makes Money

Nolato AB generates revenue through multiple key streams, primarily by manufacturing and supplying high-quality products to the medical and industrial sectors. The medical segment contributes significantly to the company's earnings, as Nolato produces critical components and devices for healthcare applications, including surgical instruments and drug delivery systems. The industrial segment includes a variety of applications, such as automotive parts and consumer products. Additionally, Nolato benefits from long-term contracts and strategic partnerships with leading companies in the healthcare and industrial markets, which provide a stable revenue base. The company also invests in innovation and sustainability, enabling it to command premium pricing for its advanced products and services.

Nolato AB Financial Statement Overview

Summary

Nolato AB demonstrates strong profitability and low leverage, with a stable gross profit margin and healthy EBIT and EBITDA margins. However, the significant decline in revenue growth and free cash flow indicates potential challenges in maintaining growth momentum.

Income Statement

Nolato AB's income statement shows a mixed performance. The TTM (Trailing-Twelve-Months) gross profit margin is stable at 17.59%, and the net profit margin is 7.66%, indicating reasonable profitability. However, the revenue growth rate has declined by 45.5%, suggesting a significant drop in sales. The EBIT and EBITDA margins are healthy at 10.17% and 14.82%, respectively, reflecting efficient operations despite the revenue decline.

Balance Sheet

The balance sheet of Nolato AB is strong with a debt-to-equity ratio of 0.32, indicating low leverage and financial stability. The return on equity (ROE) is 13.47%, showing effective use of equity to generate profits. The equity ratio stands at 56.78%, suggesting a solid equity base relative to total assets, which enhances financial resilience.

Cash Flow

Nolato AB's cash flow statement reveals some challenges. The free cash flow has decreased by 15.92%, indicating reduced cash available for reinvestment or distribution. The operating cash flow to net income ratio is 0.67, and the free cash flow to net income ratio is 0.50, showing moderate cash conversion efficiency. These figures suggest potential liquidity constraints.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.57B	9.66B	9.55B	10.77B	11.61B	9.36B
Gross Profit	1.71B	1.61B	1.34B	1.43B	1.82B	1.51B
EBITDA	1.61B	1.51B	1.28B	1.48B	1.92B	1.46B
Net Income	789.00M	658.00M	435.00M	697.00M	1.16B	806.00M
Balance Sheet
Total Assets	9.33B	9.69B	9.30B	10.01B	10.05B	8.68B
Cash, Cash Equivalents and Short-Term Investments	531.00M	672.00M	688.00M	1.01B	1.45B	1.49B
Total Debt	1.65B	1.53B	1.88B	2.03B	1.79B	2.14B
Total Liabilities	3.86B	3.95B	4.13B	4.62B	5.29B	4.99B
Stockholders Equity	5.46B	5.74B	5.17B	5.39B	4.77B	3.70B
Cash Flow
Free Cash Flow	296.00M	742.00M	355.00M	-49.00M	446.00M	791.00M
Operating Cash Flow	1.23B	1.38B	781.00M	406.00M	1.23B	1.16B
Investing Cash Flow	-814.00M	-636.00M	-444.00M	-451.00M	-782.00M	-1.70B
Financing Cash Flow	-572.00M	-798.00M	-631.00M	-487.00M	-634.00M	730.00M

Nolato AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 61.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOLA.B, the sentiment is Positive. The current price of 61.2 is above the 20-day moving average (MA) of 60.11, above the 50-day MA of 59.84, and above the 200-day MA of 58.00, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 57.20 is Neutral, neither overbought nor oversold. The STOCH value of 85.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NOLA.B.

Nolato AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NOLA.B	73 Outperform	$16.27B	20.62	14.17%	2.45%	0.40%	38.42%
VITR	71 Outperform	kr18.98B	43.02	3.34%	0.75%	-1.29%	―
ALIF.B	64 Neutral	$22.79B	57.81	7.24%	0.40%	5.14%	236.75%
VIMIAN	64 Neutral	€15.69B	44.40	4.63%	―	17.13%	―
MCAP	63 Neutral	€8.74B	44.15	15.16%	―	11.30%	-14.49%
EKTA.B	55 Neutral	kr17.77B	64.87	3.08%	4.14%	-0.90%	-70.95%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Nolato AB Corporate Events

Nolato AB Reports Strong Q3 2025 Performance and Strategic Expansion

Nolato AB reported a strong third quarter in 2025, with an increase in operating profit and EBITA margin, driven by strategic price and cost adjustments. The company continues to focus on organic growth and expanding its global footprint, particularly in Asia, while maintaining a strong financial position that supports future investments and acquisitions.

The most recent analyst rating on ($SE:NOLA.B) stock is a Hold with a SEK62.00 price target. To see the full list of analyst forecasts on Nolato AB stock, see the SE:NOLA.B Stock Forecast page.

Nolato AB to Release Q3 2025 Interim Report with Webcast Conference

Nolato AB announced it will release its interim report for the third quarter of 2025 on October 28, followed by a webcast conference call. This event will feature presentations by the President and CEO, Christer Wahlquist, and CFO, Per-Ola Holmström, who will discuss the report and answer questions. The announcement indicates Nolato’s commitment to transparency and engagement with stakeholders, potentially impacting its market perception and investor relations.

The most recent analyst rating on ($SE:NOLA.B) stock is a Hold with a SEK62.00 price target. To see the full list of analyst forecasts on Nolato AB stock, see the SE:NOLA.B Stock Forecast page.